BDBM50536834 CHEMBL4590201

SMILES FCC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1

InChI Key InChIKey=YGHHDWRITNGHCH-UHFFFAOYSA-N

Data  19 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 19 hits for monomerid = 50536834   

TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibition of ATG4B (unknown origin) using His-GATE-16-GST as substrate preincubated for 30 mins followed by substrate addition measured after 30 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of MMP9 (unknown origin) using Mca-PLGL-Dpa-AR as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetInterstitial collagenase(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of MMP1 (unknown origin) using Mca-PLGL-Dpa-AR as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetEndothelin-converting enzyme 1(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of ECE1 (unknown origin) using Mca-RPPGFSAFK (Dnp) as substrate preincubated for 20 mins followed by substrate addition by fluorescence pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCalpain-1/Calpain-2 catalytic subunit(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 600nMAssay Description:Inhibition of calpain (unknown origin) using calpain substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCaspase-9(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of caspase9 (unknown origin) using Ac-LEHD-AMC as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCaspase-8(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of caspase8 (unknown origin) using Ac-LEHD-AMC as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetNeutrophil elastase(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of neutrophil elastase (unknown origin) using MeOSu-AAPV-AMC as substrate preincubated for 20 mins followed by substrate addition by fluor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCathepsin D(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of recombinant human cathepsin D (400 residues) expressed in CHO cells using 5-FAM/QXL 520 FRET peptide as substrate preincubated for 20 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCaspase-2(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of caspase2 (unknown origin) using ICH-1 as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate reader...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCysteine protease ATG4B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 2.57E+3nMAssay Description:Inhibition of ATG4B (unknown origin) expressed in HEK293T cells coexpressing HTRA4 and Actin-LC3B-dNGLuc after 24 hrs by luciferase release assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetStromelysin-1(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of MMP3 (unknown origin) using Mca-PLGL-Dpa-AR as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCathepsin B(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 700nMAssay Description:Inhibition of recombinant human cathepsin B (332 residues) expressed in CHO cells using Z-FR-AMC as substrate preincubated for 20 mins followed by su...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCaspase-7(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of caspase7 (unknown origin) using Ac-LEHD-AMC as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetTryptase beta-2(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of tryptase beta2 (unknown origin) using Z-GPR-AMC as substrate preincubated for 20 mins followed by substrate addition by fluorescence pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCaspase-3(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of caspase3 (unknown origin) using Ac-DMQD-AMC as substrate preincubated for 20 mins followed by substrate addition by fluorescence plate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetCathepsin G(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of cathepsin G (unknown origin) using Suc-AAPF-pNA as substrate preincubated for 20 mins followed by substrate addition by fluorescence pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
TargetAngiotensin-converting enzyme(Human)
Roche Pharma Research and Early Development

Curated by ChEMBL
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of ACE (unknown origin) using Mca-RPPGFSAFK (Dnp) as substrate preincubated for 20 mins followed by substrate addition by fluorescence pla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed
LigandPNGBDBM50536834(CHEMBL4590201)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of 20S proteasome (unknown origin) using suc-LLVY-AMC as substrate preincubated for 20 mins followed by substrate addition by fluorescence...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2021
Entry Details Article
PubMed